Ginkgo Bioworks Holdings (DNA)HHS awarded $3.2M
HHS awarded Ginkgo Bioworks Holdings a contract with $3.2M committed so far.
- $3.2M
- committed so far
- Signed
- May 3, 2026
- Updated
- Aug 5, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 3, 2026Company filing · Form 8-K · Acquisition or saleCompleted buying or selling a business or assets“On April 3, 2026, Ginkgo Bioworks, Inc. (the “Seller”), a wholly owned subsidiary Ginkgo Bioworks Holdings, Inc. (the “Company”) completed the previously announced transaction (the “Transaction”) with Tower Biosecurity, Inc. also known as Perimeter Systems, Inc. (the “Purchaser”) pursuant to the Stock Purchase Agreement, dated as of February 26, 2026 (the “Purchase Agreement”), by and among the Seller, the Company,…”
- May 3, 2026 · this disclosureFederal contract · $3.2M obligatedDepartment of Health and Human Services awarded Ginkgo Bioworks Holdings, Inc.: $3.2M obligated to date
What came next
How to read USAspending.gov award record
The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.
Full guide: Contract ceiling vs obligated amount: the difference
What else is on file for Ginkgo Bioworks Holdings
For Ginkgo Bioworks Holdings, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DNA page.
How this filing works
Other disclosures at Ginkgo Bioworks Holdings
- SEC Form 4Oct 7, 2026
- SEC Form 144Oct 5, 2026
- SEC Form 13F-HRFeb 11, 2026
- SEC Form 13F-HRNov 12, 2025
- SEC Form 4Sep 10, 2025
- SEC Form 4Sep 10, 2025
Everything OQRO holds on this company is on its DNA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
